PhosphoSolutions成立于2001年，由Drs. Michael D. Browning, John W. Haycock, and Andrew J. Czernik 等一同创立，已发展成为在神经科学领域的蛋白及抗体的领先供应商。

PhosphoSolutions was founded in 2001 by Drs. Michael D. Browning, John W. Haycock, and Andrew J. Czernik who all worked together in the laboratory of Dr. Paul Greengard, co-recipient of the 2000 Nobel Prize in Medicine for his work on the role of protein phosphorylation in signal transduction in the nervous system. This expertise has led us to focus primarily on proteins of interest in the neuroscience field.

PhosphoSolutions公司的主要产品包括：

Cardiovascular

Catecholamine Signaling

Cell Markers

Cytoskeletal and Nuclear Proteins

DNA Damage

Extracellular Matrix Proteins

GABA Receptors

Glutamate Receptors and Associated Signaling Proteins

Hormone Biosynthesis

Neurodegenerative Disease

Neurogenesis and Development

Neurotransmission

Oncoproteins

RNA Processing

Signal Transduction

Steroid Hormone Receptors

Synaptic Vesicle Proteins

Uncategorized

Visual System

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

Celprogen是一家生物技术公司，为心脏病学、肿瘤学、糖尿病和神经病学的再生医学研发干细胞研究和治疗产品。Celprogen的所有生物产品，包括干细胞、癌症干细胞、IPC和包括ECM在内的培养基，均在美国制造和生产。

CELPROGEN is a biotechnology company developing stem cell research and therapeutics products for regenerative medicine in cardiology, oncology, diabetes & neurology. All of Celprogen’s biological products, including stem cells, cancer stem cells, iPC’s & media including ECM’s, are manufactured and produced in the United States of America. CELPROGEN provides novel molecular diagnostics and therapeutic product development solutions for Biotechnology, Pharmaceutical, Invitro diagnostics and academic partnership for drug discovery.

Celprogen公司的主要产品：

3D Culture Systems

Biological Reagents

Cell-Based Assay Kits

Cosmetic

Devices

ExtracellularMatrix

Human Serum Albumin (HSA)

Life Science

Normal Cells

Organ Cultures

Patient-Derived Xenografts [PDX]

Therapeutics

Tumorgenicity

Vaccine Development

Xeno-Free Media

Allele Biotechnology位于美国圣地亚哥市，主要专注于对生物过程的机制进行探索，以开发生物医学及治疗相关的技术和产品。以各个物种的iPS细胞、人类cGMP iPS细胞及衍生的细胞为材料，Allele Biotechnology利用专利性的非整合细胞编辑方法，开发了出了细胞治疗和药物筛选的技术。Allele Biotechnology具有深厚的基因组修饰和细胞荧光报告因子的经验，为客户提供优异的细胞检测解决方案。Allele Biotechnology还提供荧光蛋白、高效荧光素酶底物、基因分型试剂盒、骆驼抗体等产品；此外还在RNA干扰领域尤其独特的专利。

Allele Biotechnology and Pharmaceuticals, Inc. is a private, San Diego-based company that explores the mechanisms of biological processes to develop technologies and products for biomedical research and therapy development.

Our mission is to increase accessibility to innovative molecular biology research tools by offering cutting edge technologies in individual products and fully integrated platforms. Allele utilizes proprietary non-integrating cellular reprogramming methods to develop cell therapy and enable drug discovery through the use of human and non-human primate iPS cells, cGMP-grade human iPS cells and their derivatives. With additional expertise in genome modification and unique cell-based fluorescence sensors/reporters, Allele provides advanced cell and assay development solutions. Allele also has developed a wide variety of advanced research tools including superior fluorescent proteins, highly efficient luciferase assay substrates, genotyping kits, and camelid antibodies that have been validated for co-immunoprecipitation, histology, and flow cytometry. The Company has also been a leader in the RNAi field with its patents in Pol III promoter-driven siRNA, shRNA, and miRNA.